WeRide Inc. — Earnings Release 2004

Mar 26, 2004

Listed Company Information

FE PHARMA TECH<00399> - Results Announcement Far East Pharmaceutical Technology Co., Limited announced on 26/03/2004: (stock code: 00399 ) Year end date: 30/06/2004 Currency: HKD Auditors' Report: N/A Interim report reviewed by: Audit Committee (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/07/2003 from 01/07/2002 to 31/12/2003 to 31/12/2002 Note ('000 ) ('000 ) Turnover : 559,525 458,656 Profit/(Loss) from Operations : 165,549 121,691 Finance cost : (3,844) N/A Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : 120,387 87,665 % Change over Last Period : +37.33 % EPS/(LPS)-Basic (in dollars) : 0.059 0.0431 -Diluted (in dollars) : 0.056 0.0419 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 120,387 87,665 Interim Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: EARNINGS PER SHARE The calculation of basic and fully diluted earnings per share is based on the net profit from ordinary activity of the Group attributable to shareholders of HK$120,387,000 (2002: HK$87,665,000) and the weighted average number of ordinary shares in issued during the period of 2,039,764,139 shares (2002: 2,035,728,000 shares after adjusted for the effect of the share subdivision). The calculation of fully diluted earnings per share is based on the weighted average number of ordinary shares in issue during the period of 2,039,764,139 shares (2002: 2,035,728,000 shares after adjusted for the effect of share subdivision) plus the weighted average of ordinary shares deemed to be issued at no consideration of 110,293,561 shares (2002: 56,181,628 shares after adjusted for the effect of share subdivision) if all outstanding options have been exercised.